These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 7487376)

  • 1. N-acetyl-beta-D-glucosaminidase enzymuria as an indicator in monitoring the therapy of some rheumatic diseases with potentially nephrotoxic drugs.
    Wiland P; Szechiński J
    Arch Immunol Ther Exp (Warsz); 1994; 42(4):331-6. PubMed ID: 7487376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical evaluation of urinary N-acetyl-beta-D-glucosaminidase activity in patients receiving aminoglycoside and cephalosporin drugs.
    Naruse T; Hirokawa N; Oike S; Maekawa T
    Res Commun Chem Pathol Pharmacol; 1981 Feb; 31(2):313-29. PubMed ID: 7221185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measurement of urinary N-acetyl-b-D-glucosaminidase in adult patients with cystic fibrosis: before, during and after treatment with intravenous antibiotics.
    Etherington C; Bosomworth M; Clifton I; Peckham DG; Conway SP
    J Cyst Fibros; 2007 Jan; 6(1):67-73. PubMed ID: 16844430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [An early and specific indicator of aminoglycoside nephrotoxicity: isoenzyme B of urinary N-acetyl-beta-D-glucosaminidase (NAG)].
    Gibey R; Dupond JL; Peltier H; Iehl-Robert M; Henry JC
    Pathol Biol (Paris); 1986 May; 34(5):342-5. PubMed ID: 3534703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enzymuria determination in children treated with aminoglycosides drugs.
    Mohammadi-Karakani A; Asgharzadeh-Haghighi S; Ghazi-Khansari M; Seyed-Ebrahimi A; Ghasemi A; Jabari E
    Hum Exp Toxicol; 2008 Dec; 27(12):879-82. PubMed ID: 19273542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proximal tubule damage in patients treated with gentamicin or amikacin.
    Wiland P; Szechciński J
    Pol J Pharmacol; 2003; 55(4):631-7. PubMed ID: 14581723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary biomarkers in assessing the nephrotoxic potential of gentamicin in solitary kidney patients after 7 days of therapy.
    Gluhovschi G; Gadalean F; Gluhovschi C; Velciov S; Petrica L; Bob F; Bozdog G; Kaycsa A
    Ren Fail; 2014 May; 36(4):534-40. PubMed ID: 24456153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Urinary N-acetyl-beta-glucosaminidase as index of renal toxicity (author's transl)].
    Oudart N; Marcher K; Lacour B; Boulu RG; Guichard C
    Toxicol Eur Res; 1981 May; 3(3):149-51. PubMed ID: 7281165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary N-acetyl-beta-D-glucosaminidase activity in leukaemic children during high-dose methotrexate therapy.
    Oláh VA; Békési A; Tóth A; Kovács I; Balla G
    Haematologia (Budap); 1995; 26(3):151-7. PubMed ID: 7797145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal tubular damage: an extraintestinal manifestation of chronic inflammatory bowel disease.
    Kreisel W; Wolf LM; Grotz W; Grieshaber M
    Eur J Gastroenterol Hepatol; 1996 May; 8(5):461-8. PubMed ID: 8804875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Enzymuria and kidney diseases in childhood].
    Ehrich JH; Wurster U; Lütge M; Doehring E; Oemar B
    Monatsschr Kinderheilkd; 1986 Dec; 134(12):832-9. PubMed ID: 2881198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Urinary excretion of N-acetyl-beta-D-glucosaminidase (NAG) and its isoenzyme B as a marker of the nephrotoxicity of gentamicin: re-test from an animal model].
    Ali-Miraftab H; Bourbouze R; Bondiou MT; Percheron F
    Pathol Biol (Paris); 1988 Mar; 36(3):240-4. PubMed ID: 3283687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclosporine and renal enzyme excretion.
    Whiting PH; Thomson AW; Simpson JG
    Clin Nephrol; 1986; 25 Suppl 1():S100-4. PubMed ID: 2871955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal function in rheumatoid arthritis patients treated with methotrexate and infliximab.
    Wiland P; Wiela-Hojenska A; Glowska A; Chlebicki A; Hurkacz M; Orzechowska-Juzwenko K; Szechinski J
    Clin Exp Rheumatol; 2004; 22(4):469-72. PubMed ID: 15301246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Isoenzymes of N-acetyl-beta-D-glucosaminidase (NAG): new method of evaluating the nephrotoxicity of aminosides. Our experience with dibekacin in geriatrics].
    Gibey R; Dupond JL; Mallet H; Guerber F; Iehl-Robert M; Flausse-Parrot F; Becker M
    Nephrologie; 1986; 7(2):51-5. PubMed ID: 3736764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Influence of aminoglycosides on the activity of urinary N-acetyl-beta-D-glucosaminidase (NAG) and its isoenzymes].
    Mozer JL; Gibey R; Dupond JL; Henry JC
    Pathol Biol (Paris); 1988 Mar; 36(3):230-4. PubMed ID: 3283685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Salicylate-induced enzymuria: comparison with other anti-inflammatory agents.
    Proctor RA; Kunin CM
    Am J Med; 1978 Dec; 65(6):987-93. PubMed ID: 311157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-acetyl-beta-D-glucosaminidase urinary excretion as an early indicator of kidney dysfunction in rheumatoid arthritis patients on low-dose methotrexate treatment.
    Wiland P; Swierkot J; Szechiński J
    Br J Rheumatol; 1997 Jan; 36(1):59-63. PubMed ID: 9117176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary N-acetyl-beta-D-glucosaminidase (NAG) in aminoglycoside nephrotoxicity.
    Assadamongkol K; Tapaneya-Olarn W; Chatasingh S
    J Med Assoc Thai; 1989 Jan; 72 Suppl 1():42-6. PubMed ID: 2732646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression modes of urinary N-acetyl-beta-D-glucosaminidase in patients with chronic renal insufficiency.
    Tassi C; Mancuso F; Feligioni L; Marangi M; Capodicasa E
    Clin Chim Acta; 2004 Aug; 346(2):129-33. PubMed ID: 15256313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.